CDDF and EORTC Multi-Stakeholder Workshop on “Innovation and Access in Rare Cancers”
The Cancer Drug Development Forum (CDDF) shared on LinkedIn:
“[Last Chance to Register: CDDF and EORTC Multi-Stakeholder Workshop on ‘Innovation and Access in Rare Cancers’ (23-24 September 2024, Amsterdam)]
Register today for the upcoming multi-stakeholder meeting on ‘Innovation and Access in Rare Cancers’, organized jointly by The Cancer Drug Development Forum (CDDF) and EORTC – European Organisation for Research and Treatment of Cancer.
This hybrid event will take place on 23-24 September 2024 in Amsterdam, offering both in-person and online participation.
The workshop will brings together leading experts to evaluate the current state of play in clinical trials and exchange multi-stakeholder perspectives in order to improve access to innovative therapies for hashtagpatients with rare cancers.
Registration Deadlines
- Onsite participation: Monday 1 September 2024
- Online participation: Friday 20 September 2024 (for free registration) & Monday 16 September 2024 (for paid registration)
Don’t miss out on the opportunity to make your voice heard and engage in the insightful discussion. Collaboration is Key to accelerating and improving effective cancer treatments for patients.”
EORTC – European Organisation for Research and Treatment of Cancer shared this post, adding:
“Don’t miss out on our upcoming Multi-Stakeholder Workshop on ‘Innovation and Access in Rare Cancers’ with The Cancer Drug Development Forum (CDDF). This hybrid event takes place on 23-24 September 2024.
Register now.”
Source: CDDF/LinkedIn and EORTC/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023